Panion & Bf Biotech Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was TWD 386.131 million compared to TWD 349.763 million a year ago. Operating income was TWD 24.730 million compared to TWD 38.212 million a year ago. Net loss was TWD 2.879 million compared to net income of TWD 18.294 million a year ago. Basic loss per share was TWD 0.04 compared to basic earnings per share of TWD 0.24 a year ago. For the nine months, sales was TWD 1,055.452 million compared to TWD 1,107.957 million a year ago. Operating income was TWD 51.575 million compared to TWD 154.487 million a year ago. Net loss was TWD 9.752 million compared to net income of TWD 104.368 million a year ago. Basic loss per share was TWD 0.13 compared to basic earnings per share of TWD 1.36 a year ago.